Murae Organisor

37
Sell
  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE060601031
  • NSEID:
  • BSEID: 542724
INR
0.27
0.02 (8.0%)
BSENSE

Feb 04

BSE+NSE Vol: 47780468

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Cr
Standalone - Profit And Loss Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2025 is 26,594.83% vs -77.28% in Mar 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2025 is 2,259.07% vs -150.15% in Mar 2024

stock-summary

Interest

YoY Growth in year ended Mar 2025 is -98.55% vs -9.78% in Mar 2024

stock-summary

Profit After Tax

YoY Growth in year ended Mar 2025 is 14,060.64% vs -97.32% in Mar 2024

Compare Profit and Loss Results of Murae Organisor
Markets Mojo
Figures in Cr
standalone - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
Operating Income
854.00
10.00
844.00
8,440.00%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
854.00
10.00
844.00
8,440.00%
Expenditure (Ex Depriciation)
Stock Adjustments
10.00
0.00
10.00
0%
Raw Materials Consumed
830.00
7.00
823.00
11,757.14%
Power & Fuel Cost
0.00
0.00
0.00
0%
Employee Cost
0.00
2.00
-2.00
-100.00%
Operating Expenses
1.00
0.00
1.00
0%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
0.00
0.00
0.00
0%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
0.00
0.00
0.00
0%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
844.00
14.00
830.00
5,928.57%
Operating Profit (PBDIT) excl Other Income
10.00
-4.00
14.00
350.00%
Other Income
0.00
0.00
0.00
0%
Operating Profit (PBDIT)
10.00
-3.00
13.00
433.33%
Interest
0.00
0.00
0.00
0%
Profit before Depriciation and Tax
10.00
-4.00
14.00
350.00%
Depreciation
0.00
0.00
0.00
0%
Profit Before Taxation & Exceptional Items
10.00
-5.00
15.00
300.00%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
10.00
-5.00
15.00
300.00%
Provision for Tax
2.00
0.00
2.00
0%
Profit After Tax
7.00
-4.00
11.00
275.00%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
4.00
-10.00
14.00
140.00%
Profit Available for appropriations
11.00
-15.00
26.00
173.33%
Appropriations
11.00
-15.00
26.00
173.33%
Equity Dividend (%)
0%
0%
0.00
Earnings Per Share
0.04
-0.79
0.83
105.06%
Profit And Loss - Net Sales
Net Sales 854.82 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 26,594.83% vs -77.28% in Mar 2024

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 10.04 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 2,259.07% vs -150.15% in Mar 2024

Profit And Loss - Interest
Interest 0.00 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is -98.55% vs -9.78% in Mar 2024

Profit And Loss - Profit After Tax
Profit After Tax 7.52 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 14,060.64% vs -97.32% in Mar 2024